Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid C...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 9, 2023

Hengtong Optic-Electric Releases 2022 ESG Report at the PT Expo • Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 • Perfuze Announces Appointment of New Chair of the Board • ImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at • Stallergenes Greer Showcases Clinical Relevance and Persisting Benefits of Its Allergen Immunotherapy Treatments at 2023 EAACI C • Fairmont Mayakoba to host exclusive 2023 pride celebration • IgGenix Demonstrates Potential for an IgG4 Monoclonal Antibody-based Approach to Treating Peanut Allergy • Positive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presen • Ventas Realty, Limited Partnership Announces Upsize and Pricing of $750 Million of Exchangeable Senior Notes • SoftwareReviews Reveals the Top ESG Software Solutions That Enable Organizations to Build a Culture of Purpose and Sustainabilit • USCIB Releases Pride Month Statement, Supporting Equality and Inclusion • TIO EQUITY ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Tingo Group, Inc. Investors with Losses in Excess of $100K to Secur • Sophisticated Utility Vehicle: all-new 2024 Lexus GX Redefines SUV • Saudi Arabia: Modern means of transportation for easier Hajj • BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congres • Children's Miracle Network Hospitals® Celebrates 40th Anniversary with Celebrity Friends and Supporters • Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematol • A New Era of Three-Row Luxury: The First-Ever Lexus TX • CGTN: China stresses green development, ethnic unity in modernization drive • Providing LGBTQI+ people with a safe home in Canada

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid Corporation (RAD) Investors of Class Action and to Acti

NEW YORK , March 22 /Businesswire/ - Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Rite Aid Corporation (NYSE:RAD) (“Rite Aid” or the “Company”) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Rite Aid securities between April 26, 2018 and March 13, 2023, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/rad.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

On March 13, 2023, the United States Depart of Justice ("DOJ") released a statement "alleging that Rite Aid Dispensed Controlled Substances in Violation of the False Claims Act and the Controlled Substances Act." The statement claims that "Rite Aid knowingly filled unlawful prescriptions for controlled substances." According to the Complaint, "Rite Aid's pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers. These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid's stores.” On this news, the price of Rite Aid's stock fell $0.62, or 18.90%, to close at $2.66 per share on March 14, 2023. Rite Aid's stock dropped even further to $0.235, or 8.8%, to close at $2.57, on March 15, 2023.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/rad or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Rite Aid you have until May 19, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.